Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Virpax Pharmaceuticals, Inc. (VRPX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
OPERATING EXPENSES          
General and administrative  1.90.41.74.92.61.82.41.6
Research and development  1.31.20.32.83.33.31.71.7
    Total operating expenses  6.63.55.315.512.010.417.66.6
    Loss from operations  -3.2-1.7-3.1-7.7-5.9-5.1-4.1-3.2
   
OTHER INCOME          
Other income  0.10.10.10.10.0 0.0-0.1
    Loss before tax provision  -3.1-1.5-3.0-7.6-5.9-5.1-4.1-3.2
   
Income taxes          
    Net loss  -3.1-1.5-3.0-7.6-5.9-5.1-4.1-3.2
   
Basic and diluted net loss per share (in Dollars per share)  ($0.27)($0.13)($0.26)($0.65)($0.50)($0.44)($0.22)($0.53)
   
Basic and diluted weighted average common stock outstanding (in Shares)  11.711.711.711.711.711.76.76.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy